• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Let’s Go STEDI: Moving Beyond QALY’s to Understand the True Value of Antimicrobials and Vaccines

Monday, June 03, 2024
Breakout Session
Infectious Disease and Vaccines
29C
The value of a medicine is often judged solely by the value it brings to a patient, but preventive measures and medicines for infectious diseases benefit society, which is harder to measure. Stakeholders will unpack the concept of value and discuss the unique aspects of value assessment for antimicrobials and vaccines with a focus on the relatively new framework known as STEDI, which is comprised of five value elements: • Spectrum – The value of narrow spectrum antimicrobial agents; • Transmission – The value of reducing the spread of the disease; • Enablement – The value of enabling a variety of medical treatments; • Diversity – The value of reduction of selection pressure on pathogens; and • Insurance – The value of having a last line of treatment if all other treatments fail.
Moderator
Ted Buckley, PhD
Vice President, Government Affairs
Shionogi
Speakers
John Rex, MD
Chief Medical Officer
F2G
Scott Johnson, PhD
CEO/Founder
Medicus Economics
Ella Balasa
Patient Expert
Balasa Consulting
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS